Detection of the serum levels of some immunological parameters in patients with HBV

Authors

  • shahrazad ahmed university of diyala , college of science
  • Ziyad k. Radeef Diyala University/ College of Science / Department of Biotechnology
  • Safaa Alloul H Diyala University/ College of Science / Department of Biotechnology.
  • Eman Abbas Muhsin Iraqi Ministry of Science and Technology Environment, hhWater and Renewable Energy Directorate.
  • Qatralnada Ahmed Khalaf Higher Health Institute, Diyala, Iraq

DOI:

https://doi.org/10.36320/ajb/v16.i1.15090

Keywords:

Keyword:. IL-1β , IL-12 , IL-17A, C3,C4,HBV , ELISA .

Abstract

Introduction:. The current study set out to ascertain the serum concentrations of two complement compounds (C3 and C4) and several significant cytokines (IL-1β, IL-12, and IL-17A) in individuals infected with HBV.

Methods:.Ninety patients in all were gathered from the Baquba Teaching Hospital, and every diagnosis was made using an ELISA kit. The levels of IL-1β, IL-12, and IL-17A in serum samples from both HBV patients and healthy control groups were measured using an ELISA kit. The patient group exhibited elevated levels of IL-1β, IL-12, and IL-17A in comparison to the control group. A single radial immunodiffusion plate was utilized to compare the patient's levels of C3 and C4 to those of the control group.

Results :.When compared to the control group, the IL-1β, IL-12, IL-17A  show high levels and the C3 and C4 levels in the patients' serum were lower.

Conclusions:. It has been discovered that measuring the levels of IL-1β, IL-12, IL-17A, C3, and C4 can be useful in determining the extent of liver cell damage and forecasting how long hepatitis will take to proceed.         

 

Downloads

Download data is not yet available.

References

Araujo, Z.; González N.; de Cubeddu L.; Ziegler, R.; Waard, J.; Giampietro, F.; Garzaro, D.; Pujol, F.; Serrano, N.; and Saboin, A. (2006). Levels of Complement C3 and C4 Components in Amerindians Living in an Area with High Prevalence of Hepatitis.Mem.Inst.Oswaldo. Cruz. 101:359-64.

Heidari, Z., Moudi, B., Sagheb, M., & Moudi, H. (2016). Association of TNF-α Gene Polymorphisms with Production of Protein and Susceptibility to Chronic Hepatitis B Infection in the South East IranianPopulation. Hepat Mon, 16.

Jin, W., & Dong, C. (2013). IL-17 cytokines in immunity and inflammation. Emerging Microbes & Infections, 2(9), e60. doi:10.1038/emi.2013.58

Kapoor, R., & Kottilil, S. (2014). Strategies to eliminate HBV infection. Future Virology, 9(6), 565–585. doi:10.2217/fvl.14.36.

Khorami, S. H. H., Nejatollahi, F., & Davarpanah, M. A. (2018). Serum levels of interleukin-4, interleukin-10 and interferon-γ in patients with chronic hepatitis B infection. Hepatitis Monthly, 18(4).

Li, Z., & Jiang, J. (2021). The NLRP3 Inflammasome Mediates Liver Failure by Activating Procaspase-1 and pro-IL-1 β and Regulating Downstream CD40- Cd40l Signaling. J. Int. Med. Res, 49(9).

Mellors, J., Tipton, T., Longet, S., & Carroll, M. (2020). Viral evasion of the complement system and its importance for vaccines and therapeutics. Frontiers in Immunology, 11, 1450. doi:10.3389/fimmu.2020.01450

Motawi, T., Shaker, O. G., Hussein, R. M., & Houssen, M. (2016). Polymorphisms of α1-antitrypsin and Interleukin-6 genes and the progression of hepatic cirrhosis in patients with a hepatitis C virus infection. Balkan Journal of Medical Genetics: BJMG, 19(2), 35–44. doi:10.1515/bjmg-2016-0034

Ms, A.-L. (2015). Plasma Levels of Matrix Metalloproteinase (MMP)-2, MMP-9 and Tumor Necrosis Factor-α in Chronic Hepatitis C Virus Patients. Open Microbiol J, 9, 136–140.

Ostrycharz, E., & Hukowska-Szematowicz, B. (2022). New insights into the role of the complement system in human viral diseases. Biomolecules, 12(2), 226.

Persson, B. D., Schmitz, N. B., Santiago, C., Zocher, G., Larvie, M., Scheu, U., … Stehle, T. (2010). Structure of the extracellular portion of CD46 provides insights into its interactions with complement proteins and pathogens. PLoS Pathogens, 6(9), e1001122. doi:10.1371/journal. ppat.1001122

Ribeiro, C. R. de A., Almeida, N. A. A. de, Martinelli, K. G., Pires, M. A., Mello, C. E. B., Barros, J. J., & Paula, V. S. D. (2021). Cytokine profile during occult hepatitis B virus infection in chronic hepatitis C patients. doi:10.21203/rs.3.rs-34180/v3

Rus, H., Cudrici, C., & Niculescu, F. (2005). The role of the complement system in innate immunity. Immunologic Research, 33(2), 103–112. doi:10.1385/IR:33:2:103

Seeger, C., & Mason, W. S. (2015). Molecular Biology of Hepatitis B Virus Infection. Virology 479-480, 672-686. doi:10.1016/j.virol.2015.02.031

Şenol, A., Alayunt, N. Ö., & Solmaz, Ö. A. (2021). Role of tumor necrosis factor-α, interleukin-1β, interleukin-6 in liver inflammation in chronic hepatitis B and chronic hepatitis C. Gulhane Medical Journal, 63(3), 200–204. doi:10.4274/gulhane.galenos.2021.1338

Singhal, R., Ganey, P. E., & Roth, R. A. (2012). Complement activation in acetaminopheninduced liver injury in mice. J Pharmacol Exp Ther, 341, 377–385.

Tripathi, S., White, M. R., & Hartshorn, K. L. (2015). The amazing innate immune response to influenza A virus infection. Innate Immunity, 21(1), 73–98. doi:10.1177/1753425913508992

Wang, B., Zhao, X.-P., Fan, Y.-C., Zhang, J.-J., & Zhao, J. (2013). IL17A but Not IL-22 Suppresses the Replication of Hepatitis B Virus Mediated by Over-expression of MxA and OAS mRNA in the HepG2.2.15 Cell Line. Antiviral Res, 97(3), 285–292. doi:10.1016/j.antiviral.2012.12.018

Wang, Y., Cui, L., Yang, G., Zhan, J., Guo, L., Chen, Y., … Guo, D. (2019). Hepatitis B e antigen inhibits NF-κB activity by interrupting K63-linked ubiquitination of NEMO. Journal of Virology, 93(2). doi:10.1128/JVI.00667-18

Wu, J.-F., Hsu, H.-Y., Chiu, Y.-C., Chen, H.-L., Ni, Y.-H., & Chang, M.-H. (2015). The effects of cytokines on spontaneous hepatitis B surface antigen seroconversion in chronic hepatitis B virus infection. The Journal of Immunology, 194(2), 690–696. doi:10.4049/jimmunol.1401659

Xia, C., Liu, Y., Chen, Z., & Zheng, M. (2015). Involvement of interleukin 6 in hepatitis B viral infection. Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology, 37(2), 677–686. doi:10.1159/000430386

Zhang, H., Yan, X., Yang, C., Zhan, Q., Fu, Y., Luo, H., & Luo, H. (2020). Intrahepatic T helper 17 cells recruited by hepatitis B virus X antigen-activated hepatic stellate cells exacerbate the progression of chronic hepatitis B virus infection. Journal of Viral Hepatitis, 27(11), 1138–1149. doi:10.1111/jvh.13352

Zhang, Z., Trippler, M., Real, C. I., Werner, M., Luo, X., Schefczyk, S.,Broering, R. (2020). Hepatitis B virus particles activate toll-like receptor 2 signaling initially upon infection of primary human hepatocytes. Hepatology (Baltimore, Md.), 72(3), 829–844. doi:10.1002/hep.31112

Zhu, C., Song, H., Xu, F., Yi, W., Liu, F., & Liu, X. (2018). Hepatitis B virus inhibits the expression of complement C3 and C4, in vitro and in vivo. Oncology Letters, 15(5), 7459–7463. doi:10.3892/ol.2018.8223

Downloads

Published

2024-04-30

How to Cite

ahmed, shahrazad, k. Radeef , Z., Alloul H, S., Abbas Muhsin, E., & Ahmed Khalaf, Q. (2024). Detection of the serum levels of some immunological parameters in patients with HBV. Al-Kufa University Journal for Biology, 16(1), 66-71. https://doi.org/10.36320/ajb/v16.i1.15090

Share